GemVax&KAEL Revenue

GemVax&KAEL had revenue of 12.37B KRW in the quarter ending March 31, 2025, a decrease of -16.01%. This brings the company's revenue in the last twelve months to 60.33B, down -15.34% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.

Revenue (ttm)

60.33B

Revenue Growth

-15.34%

P/S Ratio

47.54

Revenue / Employee

314.24M

Employees

192

Market Cap

2,868.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%
Dec 31, 2020	65.66B	23.00B	53.91%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	308.10T
SK hynix	71.40T
Samsung Biologics	4,898.69B
LG Energy Solution	25.76T
Hanwha Aerospace	15.28T
Hyundai Motor Company	178.98T
Kia Corporation	109.25T
KB Financial Group	14.93T

Revenue Rankings